Medication info

Tetraffepir Injection

Prescription medicationInjections
Ingredient · strength
L-Leucine›0.74g / 100mLL-Lysine Acetate›0.93g / 100mLL-Methionine›0.43g / 100mLL-Valine›0.62g / 100mLL-Serine›0.65g / 100mLL-Arginine›1.2g / 100mLL-Alanine›1.4g / 100mLL-Isoleucine›0.5g / 100mLL-Threonine›0.44g / 100mLL-Tryptophan›0.2g / 100mLL-Tyrosine›0.04g / 100mLL-Phenylalanine›0.51g / 100mLL-Proline›1.12g / 100mLL-Histidine›0.3g / 100mLAnhydrous Sodium Glycerophosphate›0.418g / 100mLGlycine›1.1g / 100mLSodium Acetate Hydrate›0.562g / 100mLPotassium Chloride›0.448g / 100mLCalcium Chloride Hydrate›0.074g / 100mLTaurine›0.1g / 100mLMagnesium Sulfate Hydrate›0.247g / 100mLZinc Sulfate Hydrate›0.0023g / 100mLGlucose Monohydrate›14.3g / 100mLSoybean Oil›6g / 100mLPurified Fish Oil (High Dose Omega-3 Fatty Acids)›3g / 100mLPurified Olive Oil›5g / 100mLTriglycerides Medium-Chain›6g / 100mL
Manufacturer / importer
Daehan Pharmaceutical Co., Ltd.
Appearance
Consists of a colorless, transparent plastic inner bag divided into 3 compartments and an outer packaging, with an oxygen absorber in between. Each inner bag contains a colorless to pale yellow transparent amino acid solution.
Packaging
217 mL/bag (A solution: 68 mL, B solution: 118 mL, C solution: 31 mL), 241 mL/bag (A solution: 76 mL, B solution: 131 mL, C solution: 34 mL), 362 mL/bag (A solution: 114 mL, B solution: 197 mL, C solution: 51 mL), 500 mL/bag (A solution: 157.5 mL, B solution: 272 mL, C solution: 70.5 mL), 603 mL/bag (A solution: 190 mL, B solution: 328 mL, C solution: 85 mL), 1206 mL/bag
Approval status
Active

MFDS item code 202106268 · Notified 2021.09.01

Summary

Main use
Improvement of nutritional deficiencies (calories, amino acids, essential fatty acids, etc.) through intravenous nutritional support
Who uses it
Adults · Children
Adult dosage
The dose and infusion rate are determined according to the patient's ability to eliminate fat and metabolize nitrogen and glucose, and nutritional requirements. The dose should be individualized in consideration of the patient's condition, body weight, nutritional and energy requirements, and additional oral/enteral intake. Trace elements, vitamins, electrolytes, etc. may be added according to the patient's condition. The nitrogen requirement for maintaining body protein depends on the patient's condition (e.g., nutritional status and catabolic stress or anabolism). Children 12 years and older and adults - Patients with normal nutritional status or mild metabolic stress: amino acids 0.6-0.9 g/kg per day (nitrogen 0.10-0.15 g/kg) - Patients with moderate to high metabolic stress, regardless of nutritional imbalance: amino acids 0.9-1.6 g/kg per day (nitrogen 0.15-0.25 g/kg) In very special cases (e.g., burns or marked anabolic states), nitrogen requirements may be higher. Dose A daily dose of 20-40 mL/kg of this medicine corresponds to amino acids 0.6-1.3 g/kg (nitrogen 0.10-0.20 g/kg) and total energy 14-28 kcal/kg (non-protein energy 11-22 kcal/kg)). This meets the requirements of most patients. In obese patients, the dose should be based on predicted normal body weight. Infusion rate The infusion rate must not exceed 3.0 mL/kg per hour (equivalent to amino acids 0.10 g/kg, glucose 0.21 g/kg, and fat 0.08 g/kg). The recommended infusion duration is 14-24 hours. Maximum daily dose The maximum daily dose depends on the patient's clinical condition and may vary from day to day. The recommended maximum daily dose is 40mL/kg. The recommended maximum daily dose of 40mL/kg provides amino acids 1.3 g/kg (nitrogen 0.20 g/kg), glucose 2.8g/kg, fat 1.1g/kg, and total energy 28 kcal/kg (equivalent to non-protein energy 24 kcal/kg). Administer by intravenous infusion through a peripheral or central vein.
Children's dosage
Children 2-11 years: Pediatric patients show greater variability than adult patients; therefore, regularly adjust the dose according to requirements, up to 40 mL/kg of this medicine per day. The recommended maximum daily dose is 40mL/kg. The infusion rate must not exceed 3.0 mL/kg per hour (equivalent to amino acids 0.10 g/kg, glucose 0.21 g/kg, and fat 0.08 g/kg). The recommended infusion duration is 12-24 hours. When administering the recommended maximum daily dose, administer over at least 13 hours, except in special circumstances. The maximum daily dose depends on the patient's clinical condition and may vary from day to day. The recommended maximum daily dose of 40 mL/kg provides amino acids 1.3 g/kg (nitrogen 0.2 g/kg), glucose 2.8 g/kg, fat 1.1 g/kg, and total energy 28 kcal/kg (equivalent to non-protein energy 22 kcal/kg).

Ingredients

Manufacturer
Daehan Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of nutritional deficiencies (calories, amino acids, essential fatty acids, etc.) through intravenous nutritional support

View approved original text

This medication provides calories, amino acids, essential fatty acids, and omega-3 fatty acids intravenously to pediatric and adult patients over 2 years old, when oral or gastrointestinal nutrition is difficult. It helps improve patients' nutritional status and maintain balanced nutrition. It is primarily used to address insufficient nutrition in patients and to support recovery.

Dosage and Administration

Adult dosage

The dose and infusion rate are determined according to the patient's ability to eliminate fat and metabolize nitrogen and glucose, and nutritional requirements. The dose should be individualized in consideration of the patient's condition, body weight, nutritional and energy requirements, and additional oral/enteral intake. Trace elements, vitamins, electrolytes, etc. may be added according to the patient's condition. The nitrogen requirement for maintaining body protein depends on the patient's condition (e.g., nutritional status and catabolic stress or anabolism). Children 12 years and older and adults - Patients with normal nutritional status or mild metabolic stress: amino acids 0.6-0.9 g/kg per day (nitrogen 0.10-0.15 g/kg) - Patients with moderate to high metabolic stress, regardless of nutritional imbalance: amino acids 0.9-1.6 g/kg per day (nitrogen 0.15-0.25 g/kg) In very special cases (e.g., burns or marked anabolic states), nitrogen requirements may be higher. Dose A daily dose of 20-40 mL/kg of this medicine corresponds to amino acids 0.6-1.3 g/kg (nitrogen 0.10-0.20 g/kg) and total energy 14-28 kcal/kg (non-protein energy 11-22 kcal/kg)). This meets the requirements of most patients. In obese patients, the dose should be based on predicted normal body weight. Infusion rate The infusion rate must not exceed 3.0 mL/kg per hour (equivalent to amino acids 0.10 g/kg, glucose 0.21 g/kg, and fat 0.08 g/kg). The recommended infusion duration is 14-24 hours. Maximum daily dose The maximum daily dose depends on the patient's clinical condition and may vary from day to day. The recommended maximum daily dose is 40mL/kg. The recommended maximum daily dose of 40mL/kg provides amino acids 1.3 g/kg (nitrogen 0.20 g/kg), glucose 2.8g/kg, fat 1.1g/kg, and total energy 28 kcal/kg (equivalent to non-protein energy 24 kcal/kg). Administer by intravenous infusion through a peripheral or central vein.

Children's dosage

Children 2-11 years: Pediatric patients show greater variability than adult patients; therefore, regularly adjust the dose according to requirements, up to 40 mL/kg of this medicine per day. The recommended maximum daily dose is 40mL/kg. The infusion rate must not exceed 3.0 mL/kg per hour (equivalent to amino acids 0.10 g/kg, glucose 0.21 g/kg, and fat 0.08 g/kg). The recommended infusion duration is 12-24 hours. When administering the recommended maximum daily dose, administer over at least 13 hours, except in special circumstances. The maximum daily dose depends on the patient's clinical condition and may vary from day to day. The recommended maximum daily dose of 40 mL/kg provides amino acids 1.3 g/kg (nitrogen 0.2 g/kg), glucose 2.8 g/kg, fat 1.1 g/kg, and total energy 28 kcal/kg (equivalent to non-protein energy 22 kcal/kg).

Precautions

This medication must be used strictly according to a doctor's instructions, and should not be stopped or changed based on self-judgment. If allergic reactions such as fever, chills, skin rash, or difficulty breathing occur, discontinue administration immediately and inform medical personnel. Caution is necessary as dangerous precipitates can occur when used with other intravenous calcium-containing products or certain antibiotics; do not administer them simultaneously. Particularly, this medication may be risky for premature infants or low-birth-weight infants, and should be avoided in cases of severe respiratory illness. Patients with allergies to fish, eggs, soybeans, peanuts, or patients with severely impaired liver or kidney function, and patients in acute shock should not use this medication. It should not be administered to children under 2 years of age. Patients with impaired kidney function, diabetes, or liver dysfunction should be particularly cautious when using this medication and should administer it under strict medical supervision. During administration, regular checks of lipid levels, electrolyte concentrations, blood glucose, and liver enzyme levels in the blood should be conducted to ensure no abnormalities exist. Overdose may lead to hyperlipidemia, hyperglycemia, allergic reactions, etc., and the rate and dosage of administration must be strictly adjusted. Aseptic conditions must be maintained to prevent infections during administration and the injection site should be frequently monitored to avoid thrombosis or inflammation. Women who are pregnant or breastfeeding should only use this medication under medical judgment due to insufficient assurance of safety.

Side effects

fever, chills, rash, shortness of breath, tachycardia, loss of appetite, nausea, vomiting, increased plasma enzyme levels, thromboembolic venous inflammation, hypotension, hypertension, mild fever elevation, headache, dizziness, anaphylactic or anaphylactoid reaction, skin rash, hives, flushing, warmth, coldness, cyanosis, pallor, pain (neck, back, bones, chest, lower back), hyperlipidemia, fever, fatty infiltration, jaundice, hepatomegaly, splenomegaly, anemia, leukopenia, thrombocytopenia, coagulopathy, hemolysis, reticulocytosis, abnormal liver function test results, coma, nausea, vomiting, chills, sweating, increase in body temperature, hyperglycemia, allergic reaction, constipation, diarrhea, pneumonia, stomatitis, delirium, dyspepsia, abdominal pain, hypoalbuminemia, insomnia, febrile neutropenia, generalized weakness, edema, urinary disorders, hematuria, weight loss, hypoglycemia, hypocalcemia, heartburn, aspiration pneumonia, hematemesis, rhinorrhea, extravasation at the injection site, phlebitis, site reaction, dysuria, cough, infection, thromboembolism, hematochezia, vasculitis, skin infection, pulmonary edema, sepsis, Clostridium infection, candidiasis, dental disease, pancreatitis, weight gain, fluid overload, spinal cord compression, vaginal bleeding, tissue fluid retention, hyponatremia, intestinal obstruction, cervical cancer, gum bleeding, pharyngeal disease, depression, pressure sores, urinary incontinence, urinary tract infection, malnutrition, laceration, gastroesophageal reflux disease, Aspergillosis, oral thrush, neuropathic pain, neuropathy, esophagitis, blister, wound infection, epigastric pain, frequent urination, anxiety, ascites, abdominal discomfort, atelectasis, peripheral neuropathy, hiccups, colitis, leg edema, cerebral ischemia, acute renal failure, myalgia, hypersensitivity, exacerbation of hypertension, conjunctival hemorrhage, hemoptysis, sputum disorders, voice disorders

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air exposure and kept in a cool place below 25 degrees Celsius. Take care not to freeze, as freezing may change the components of the medication.

Appearance and packaging

Appearance

Consists of a colorless, transparent plastic inner bag divided into 3 compartments and an outer packaging, with an oxygen absorber in between. Each inner bag contains a colorless to pale yellow transparent amino acid solution.

Package unit

217 mL/bag (A solution: 68 mL, B solution: 118 mL, C solution: 31 mL), 241 mL/bag (A solution: 76 mL, B solution: 131 mL, C solution: 34 mL), 362 mL/bag (A solution: 114 mL, B solution: 197 mL, C solution: 51 mL), 500 mL/bag (A solution: 157.5 mL, B solution: 272 mL, C solution: 70.5 mL), 603 mL/bag (A solution: 190 mL, B solution: 328 mL, C solution: 85 mL), 1206 mL/bag

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.